Shire plc (SHPGY)

Q3 2011 Earnings Call

October 28, 2011 9:00 am ET


Michael Cola - President of Specialty Pharmaceuticals, Member of Senior Staff Committee and Member of Management Committee

Graham Hetherington - Chief Financial Officer, Principal Accounting Officer and Director

Sylvie Gregoire - President of Human Genetic Therapies Business and Member of Management Committee

Angus Russell - Chief Executive Officer and Executive Director

Jeff Jonas - Senior Vice President of Research & Development for Pharmaceuticals Business

Eric Rojas - Director of Investor Relations - North America


Ken Cacciatore - Cowen and Company, LLC, Research Division

Thomas J. Russo - Robert W. Baird & Co. Incorporated, Research Division

Gary Nachman - Susquehanna Financial Group, LLLP, Research Division

David M. Steinberg - Deutsche Bank AG, Research Division

Keyur Parekh - Goldman Sachs Group Inc., Research Division

Luisa Hector - Crédit Suisse AG, Research Division

Peter Verdult - Morgan Stanley, Research Division

Graham Parry - BofA Merrill Lynch, Research Division

Frank H. Pinkerton - SunTrust Robinson Humphrey, Inc., Research Division

Guillaume van Renterghem - UBS Investment Bank, Research Division



Good day, ladies and gentlemen, and welcome to the Shire's 2011 Third Quarter Results hosted by Eric Rojas. My name is Joan, and I'm your event manager. [Operator Instructions] I would like to advise all parties that this call is being recorded for replay purposes, and now, I'd like to hand it over to Eric. Go ahead please.

Eric Rojas

Good morning, and good afternoon, everyone. Thank you for joining us today for Shire's Third Quarter 2011 Financial Results.

If you liked this article you might like

Shire PLC (SHPGY): Today's Featured Drugs Loser

Shire PLC (SHPGY): Today's Featured Health Care Winner

Shire's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Shire PLC (SHPGY): Today's Featured Health Care Winner

Shire Stock To Go Ex-dividend Tomorrow (SHPGY)